Home > Insider Trading > Filing (0001604689-17-000004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1457612	Genocea Biosciences Inc.	GNCA	Biological Products, (No Disgnostic Substances) (2836)	510596811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1604689	Jonathan Poole	C/O Genocea Biosciences, Inc. 100 Acorn Park Drive, 5Th Floor Cambridge MA 02140	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-05-03	7,937	$0.00	25,150	No	4	A	Direct
Common Stock	Acquisiton	2017-05-03	23,810	$0.00	48,960	No	4	A	Direct
Common Stock	Disposition	2017-05-08	6,213	$6.51	42,747	No	4	S	Direct
Common Stock	Disposition	2017-05-10	3,500	$6.13	39,247	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	F	Direct

Footnotes

The restricted stock units ("RSUs") were granted in accordance with Genocea Biosciences, Inc.'s (the "Company") 2014 Equity Incentive Plan (the "Plan") and vested immediately upon grant.
The RSUs were granted in accordance with the Plan and will vest in full 18 months from the grant date, subject to Mr. Poole's continued employment with the Company.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.50 to $6.54, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Shares sold to cover taxes on RSUs that vested on May 3, 2017.